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Available online 22 December 2016Background: Children with a single systemic right ventricle, such as in hypoplastic left heart syndrome (HLHS),
frequently experience reduced exercise capacity. Elucidating the causes could help with optimising treatment
strategies.
Methods: Prospective data from 10 consecutive symptomatic patients with HLHS undergoing clinical cardiac
magnetic resonance with catheterisation (XMR) were analysed. Mean age 8.6 years (range 3.5–11.6 years),
mean time since Fontan completion 5.5 years.MR-compatible catheters were placed in the systemic right ventri-
cle and branch pulmonary arteries to record pressures at rest, with dobutamine infusion at 10mcg/kg/min and at
20 mcg/kg/min. Cine short-axis stacks of the ventricle were performed at each condition and used to construct
pressure–volume loops.
Results: Compared to rest, cardiac index increased with low-dose dobutamine (p b 0.01) with no further rise at
peak stress despite a further, albeit, blunted rise in heart rate (p = 0.002). A fall in stroke volume occurred
(p = 0.014) despite good contractility (74% increase, p = 0.045) and a well-coupled ventriculo-arterial ratio.
End-diastolic pressure and early active relaxation, markers of diastolic function, were normal at rest. However,
preload fell at peak stress (p b 0.008) while pulmonary vascular resistance (PVR) was low throughout. This
group of HLHS patients demonstrated a fall in SV at peak stress, coinciding with a fall in preload.
Conclusions:Markers of systolic and diastolic function remained normal. Failure to adequately ﬁll the ventricle
implies a ceiling of maximal ﬂow through the Fontan circuit despite low PVR.
© 2016 Published by Elsevier Ireland Ltd.Keywords:
Magnetic resonance imaging
Congenital heart disease
Hypoplastic left heart syndrome
Catheterisation
Fontan procedure1. Background
Despite improvements in life expectancy, patients with single ven-
tricle physiology experience premature circulatory failure [1]. Children
with a systemic right ventricle (RV), such as in hypoplastic left heart
syndrome (HLHS), have the highest incidence of exercise intolerance
[2]. There is evidence that this is related to a limited ability to increase
cardiac index (CI) [3]. However, the physiological mechanisms under-
pinning these ﬁndings remain incompletely understood.
Recent work has shown that the application of pharmacological stress
in this group of patients results in a fall in end-diastolic volume (EDV)
with a blunted cardiac output response. Cardiac output is augmentedability and freedom from bias of
ces, King's College London, 4th
H, United Kingdom.only through increasingheart rate [4] [5]. Evidence suggests impaired sys-
tolic and diastolic function may contribute towards reduced cardiac out-
put [6,7], but load-dependent measures of function in this group of
patients may give inconsistent results [8–10]. Magnetic resonance imag-
ing combined with catheterisation (XMR) [11,12] permits invasive mea-
surements of pressure with simultaneous quantiﬁcation of blood ﬂow
and ventricular volume [13]. This assessment offers useful insight into
the energetic performance of the RV [14] [15] including the opportunity
to construct pressure–volume loops [16,17] to enable a comprehensive
analysis of the physiology through assessment of load-independent indi-
ces [15,18]. However, measuring cardiac function solely under baseline
conditions in patientswith HLHSmaymask dysfunction seen only during
exertion. Pharmacological stress therefore offers an alternativemethod to
simulate some of the physiological effects of higher heart rates (HR) in
this group of patients [5,18].
In this study, we assessed a group of children with HLHS exhibiting
symptoms of diminished exercise capacity.We focused on assessing ven-
tricular energetics and function while applying incremental dobutamine
440 J. Wong et al. / International Journal of Cardiology 230 (2017) 439–446stress to study the changes in physiology through a range of heart rates.
Wehypothesized that stepwise increments of dobutaminemight unmask
ventricular dysfunction only seen at the highest heart rates helping us to
further understand the reasons for a blunted response in CI.
2. Methods
2.1. Study design
Prospective data were collected from 10 consecutive studies on patients with HLHS
undergoing clinical XMR. Patients were referred by their clinician for assessment of exer-
cise intolerance. All had undergone completion of a total cavopulmonary anastomosis at
our institution and were scanned under general anaesthesia using low-dose inhaled
sevoﬂuorane with remifentanyl while maintaining normocarbia as per institutional pref-
erence (Ethical approval 09/H0804/62). All subjects underwent cardiac magnetic reso-
nance imaging (MRI) on a 1.5-Tesla scanner (Achieva; Philips Healthcare, Best The
Netherlands) using a two-channel coil. The research protocol is outlined in Fig. 1.
2.2. Cardiac catheterization
A ﬂuid ﬁlled magnetic resonance (MR)–compatible catheter was placed in the sys-
temic RV under X-ray guidance. A second MR-compatible catheter was placed in one of
the branch pulmonary arteries. A mean pulmonary artery and mean pulmonary capillary
wedge pressure were recorded and the difference used to calculate the trans-pulmonary
gradient. Pressures were recorded on a haemodynamic tracer system (TechnoMedMedi-
cal Solutions, UK). Patients received a standard heparin bolus for anti-coagulation, which
wasmonitored using activated clotting time. Once the catheters were in-place, the patient
was transferred to the MR scanner to undergo simultaneous pressure and volume mea-
surements [19].
2.3. Cine MRI
A retrospectively ECG-gated balanced-steady state-free precession (bSSFP) cine
short-axis stack planned parallel to the atrio-ventricular valve plane of the systemic ven-
tricle was performed. Images were acquired during end expiratory breath-holds covering
apex to base. Typical imaging parameters: TR=3.0–3.6ms; TE= 1.5–1.8ms; parallel im-
aging (SENSE) factor 2; ﬂip angle 60°; ﬁeld of view 200–400 mm, slice thickness 6–8 mm
depending on patient size, in-plane resolution 1.3–2.0 mm; acquired temporal resolution
30–40 phases, breath-hold duration 5–7 s per slice, 10–14 slices to cover the heart.Fig. 1.Workﬂow for composing pressure–volume loops using cine CMR and invasive ventricula
Fontan circuit. Ventricular pressure traces are synchronised to CMR volumetrics to generate a2.4. Two-dimensional phase contrast ﬂow CMR
A free-breathing retrospectively ECG-triggered two-dimensional (2D) phase contrast
(PC) ﬂowwas acquired orthogonal to the ascending aorta at the level of the right pulmo-
nary artery (RPA) and additionally orthogonal to the superior and inferior vena cavae (SVC
and IVC)with NSA 3, spatial resolution 1.5 × 1.5 × 6mm, acquired temporal resolution 30
phases. This was used to determine aorto-pulmonary collateral (APC) ﬂow.
2.5. Pharmacological stress protocol
Invasive ventricular pressures, pulmonary, and pulmonary capillary wedge pressures
were recorded at rest and repeated with infusion of dobutamine ﬁrst at 10 mcg/kg/min
and then at 20 mcg/kg/min. Simultaneous cine short-axis stacks of the ventricle with
aorta, left pulmonary artery (LPA), and right pulmonary artery (RPA) 2D PCﬂowwere per-
formed during each condition. The protocol was terminated if the patient became haemo-
dynamically unstable (a supra-physiological rise in blood pressure or HR).
2.6. Analysis
Analysis of CMR volumetric and ﬂow data was performed using a Viewforum work-
station (Viewforum 2.0, Philips Healthcare, Best, Netherlands). Segmentation of the ven-
tricular cavity involved manual tracing of endocardial contours for each slice at all time
points. The position of the atrio-ventricular valve was conﬁrmed by linking the short-
axis stack to a long-axis view of the ventricle. Calculation of 2D PC ﬂow stroke volume
(SV) was performed by contouring a region of interest encompassing the vessel for all
phases of the cardiac cycle.
Aorto-pulmonary collateral (APC) ﬂow was calculated as follows:
QAPC ¼ QAo− QSVC þ QIVCð Þ
where
Q = ﬂow
APC = aorta-pulmonary collateral
Ao = ascending aorta
SVC = superior vena cava
IVC = inferior vena cava
Pressure–volume loops were constructed for each condition. This is shown in Fig. 1.
The end-systolic pressure–volume relationship (ESPVR) was derived at each state from
a validated maximal pressure (Pmax) estimation method using the average of multiple
pressures [20]. The slope of the ESPVR represents the elastance of the ventricle (Ees).r pressure measurements. MR-compatible catheters are positioned within the RV and the
pressure–volume loop.
Table 1
Patient demographics.
ID &
morphology
Age (y) Weight
(kg)
Time since Fontan
(y)
Saturations
(%)
TR
1. HLHS 9.2 26.5 5.7 98 Mild
2. HLHS 11.6 45.9 8.9 95 None
3. HLHS 9.2 20 6.7 92 None
4. HLHS 5.9 21.5 3.5 95 None
5. HLHS 5.8 16 3.5 93 Mild
6. HLHS 9.1 14.1 6.5 98 Mild
7. HLHS 5.5 16 0.5 93 Mild
8. HLHS 7.6 30 4.2 92 None
9. HLHS 10.1 34.4 8 93 Mild
10. HLHS 12.2 34.6 6.5 96 None
Mean (± SD) 8.6 (±2.3) 25.8 (±10.2) 5.5 (±2.6) 95 (±2)
HLHS indicates hypoplastic left heart syndrome.
TR indicates tricuspid regurgitation.
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the artery (Ea). Ventriculo-arterial coupling is represented by the ratio of Ees to Ea. The area
within the pressure–volume loop was used to establish ventricular stroke work and mul-
tiplied by HR to calculate power. Tau (τ), the early relaxation constant, was calculated
from the reciprocal of the natural logarithm of the early maximal fall in ventricular pres-
sure during diastole.
Preload values were taken from multiple averaged measurements and calculated
using a modiﬁed La Place formula [21]:
σ ¼ Pr
h 2þ h
r
 
where
σ=mean end-diastolic wall stress
P = RV pressure (dynes/cm2)
r = endocardial radius of curvature (cm)
h = wall thickness (cm)
The branch pulmonary artery ﬂows and trans-pulmonary gradient were used to cal-
culate pulmonary vascular resistance [13].
2.7. Statistical analysis
Statistical analysis was performed using SPSS version 22. Tests of normality were per-
formed using the Shapiro–Wilk method. Continuous variables were expressed asmean±
SD. One-way analysis of variance (ANOVA) was used to assess differences between rest
and each condition of dobutamine using Bonferroni-adjusted post hoc t tests. Throughout,
a p value of b0.05 was considered signiﬁcant. Inter-user variabilities for manual segmen-
tation of CMR were determined by intra-class correlation coefﬁcients using a two-way
random model with absolute agreement.
3. Results
Ten consecutive studieswere performedwith all patients having un-
dergone staged palliation for HLHS. All were prospectively recruited and
all tolerated the full dobutamine protocol. Table 1 shows the demo-
graphics. Mean age, 8.6 years (range 3.5–11.6 years); mean weight,
25.8 kg (range 16–46 kg); mean time since Fontan completion,
5.5 years (range 0.5–9 years). No signiﬁcant tricuspid regurgitation in
any patient. All subjects recruited into the study were referred for as-
sessment of reduced exercise capacity.
3.1. MRI-derived indices of cardiac function
Tables 2 and 3 show haemodynamic response and MRI-derived pa-
rameters. Ejection fraction (54.0 ± 6.7%) was in the normal range, but
baseline CIwas low (2.7± 0.6 L/min/m2) compared to published values
for healthy children [22]. During administration of 10 mcg/kg/min do-
butamine, there was an expected rise in CI (p= 0.01). This was driven
solely by a rise in HR (p= 0.0001). SV remained the same as although
ESV fell (p = 0.001), there was a similar fall in EDV (p = 0.0001). At
maximumstresswith 20mcg/kg/min dobutamine, therewas no further
increase in CI, HR rose (p=0.002); however, SV fell (p=0.045) as the
fall in EDV was greater than the fall in ESV.
3.2. Contractility and coupling
Fig. 2 shows the XMR-derived indices of contractility and coupling.
Contractility (as measured by end-systolic elastance, Ees) increased
67% during the low-dose dobutamine stress (10 mcg/kg/min) (p =
0.045) with no further increase with dobutamine 20 mcg/kg/min. This
was accompanied by a stepwise increase in afterload (as measured by
arterial elastance, Ea), which reached signiﬁcance at dobutamine 20
mcg/kg/min (p= 0.012).
The ventriculo-arterial coupling ratio (Ees:Ea) was 1.45± 0.2 at rest.
It remained adequately coupled during administration of incremental
doses of dobutamine due to increases in both contractility and afterload.3.3. Ventricular work
Fig. 3a shows pressure–volume loops for each condition of dobuta-
mine. During dobutamine stress, although there was a change in the
shape of the loop, stroke work did not alter from resting conditions;
however, large corresponding increases in HR meant cardiac power in-
creased signiﬁcantly (114%) with dobutamine 10 mcg/kg/min (p =
0.001) but plateaued with dobutamine 20 mcg/kg/min as the late fall
in SV offset any further incremental rise in power (Figure 3b).
3.4. Myocardial relaxation
Parameters of diastolic functionwere normal at rest (Table 4) with an
end-diastolic pressure (EDP) and early relaxation constant (Tau) that
compared to the literature. EDP remained low throughout the study,
which is not in keeping with the rise that usually occurs during stress in
healthy subjects. When indexing EDP to the RVEDV (mmHg/ml) to give
an indexed ﬁlling pressure, there was no signiﬁcant change with applica-
tion of stress (p = 0.99). There was an overall stepwise improvement in
myocardial relaxation as demonstrated by the fall in Tau, which reached
signiﬁcance at dobutamine at 20 mcg/kg/min (p= 0.038).
3.5. Preload and PVR
Therewas a stepwise fall in preload,which reached signiﬁcancewith
dobutamine at 20 mcg/kg/min (p=0.008). The relationship of preload
to SV is shown in Fig. 4. The change in preload was not related to PVR,
which was in the normal range (1.7 ± 1.2 WU.m2) and remained un-
changed throughout (Table 4). APC ﬂow contributed 12.9% of cardiac
output at rest (Table 3).
3.6. Reproducibility of ventricular volumes and aortic ﬂow
Intra-class correlation (95% conﬁdence interval) was 0.97 (0.80–
0.99) for EDV, 0.95 (0.82–0.980) for ESV, 0.95 (0.82–0.98) for SV, and
0.89 (0.58–0.97) for EF.
4. Discussion
In this study, we used XMR to gain further insights into the causes of
reduced functional status in patients with HLHS post-Fontan. We
hypothesised that abnormalities in systolic or diastolic indices of the sys-
temic right ventriclemight become apparentwith application of stepwise
increments of dobutamine stress and thesemay inpart explain the abnor-
mal CI and blunted response to stress previously demonstrated in the lit-
erature [4]. However, in this study, using pressure–volume loop-derived
indices of function, we did not ﬁnd any abnormalities in systolic or dia-
stolic ventricular function. In fact, our symptomatic group of patients
Table 2
Haemodynamic response.
ID Heart rate (bpm) iCO (l/min/m2) EF % Mean BP (mmHg)
Rest Dob10 Dob20 Rest Dob10 Dob20 Rest Dob10 Dob20 Rest Dob10 Dob20
1 53 113 127 2.2 5.0 4.7 49 66 63 46 66 60
2 69 107 142 2.3 3.9 4.3 49 65 67 71 122 120
3 59 95 140 2.1 4.1 4.1 57 81 73 59 110 153
4 76 115 138 2.4 3.9 4.3 46 55 60 59 104 99
5 60 128 141 3.0 4.9 5.3 56 58 66 46 60 73
6 68 95 105 3.3 4.1 4.4 61 70 71 44 56 57
7 65 120 132 3.9 4.4 4.6 67 69 76 41 43 48
8 62 113 141 2.9 4.4 3.4 49 65 55 51 91 81
9 68 141 149 2.5 4.1 4.4 49 68 64 55 71 66
10 69 122 132 2.3 3.1 3.0 57 62 66 42 80 81
Mean 65 115* 135 * 2.7 4.2 * 4.2 * 54.0 65.9 * 66.1 * 51 80 † 84 †
±SD (±7) (±14) (±12) (±0.6) (±0.4) (±0.6) (±6.7) (±7.1) (±6.2) (±10) (±26) (±32)
ANOVA p value 0.0001 0.0001 0.001 0.012
Post-hoc compared to rest * denotes p b 0.01 † denotes p b 0.05
bpm indicates beats per minute; iCO, indexed cardiac output; EF, ejection fraction; BP, blood pressure; Dob, dobutamine.
442 J. Wong et al. / International Journal of Cardiology 230 (2017) 439–446had normal functional indices and themajor factor limiting SV and CIwas
a fall in preload with a corresponding plateau in indexed EDP.
4.1. Relevance to previous studies
Previous studies have shown [4] that CI is low at rest with a blunted
response to dobutamine stress compared to normal left ventricles. The
rise in CI with dobutamine 10 mcg/kg/min is driven by an increase in
HR, and there is no further rise in CI at peak stress [5]. This is because
SV does not rise with dobutamine 10 mcg/kg/min and in fact falls
with dobutamine 20 mcg/kg/min. This inability to increase SV is driven
by an incremental fall in EDV and is unrelated to PVR. The use of XMR
allowed us to gain additional insights into the physiology of the blunted
CI response in these HLHS post-Fontan patients during dobutamine
stress. Dobutamine acts on the adrenergic receptors of the heart and
also on peripheral receptors. At low levels, it hasmainly inotropic effects
on the myocardium with increasing chronotropic effects at higher
levels. At high levels, it also reduces peripheral afterload. Dobutamine
has been shown to be safe and reliable at levels up to 40 mcg/kg/min
[12,23–25] [26]. Dobutamine has a logarithmic relationship to the
dose response curve. Once the early dose response is achieved, a dou-
bling of the dose leads to a doubling of the haemodynamic effect [12].
In healthy adults, dobutamine increases SV while EDV remains stable.
These are similar to the volumetric changes seen during exercise [27].
Studies assessing ventricular function in response to dobutamine [5,
18,24] and exercise [28] have shown similar ﬁndings in patients post-
Fontan: a low baseline CI and with moderate stress a HR-driven rise inTable 3
MRI-derived volumetric indices.
ID iRVEDV (ml/m2) iRVESV (ml/m2)
Rest Dob10 Dob20 Rest Dob1
1 80 65 58 38 20
2 65 53 42 31 17
3 63 53 40 26 10
4 69 60 50 36 26
5 80 63 49 30 24
6 81 61 54 31 17
7 72 56 44 12 19
8 97 60 44 49 21
9 74 45 46 37 13
10 58 40 35 25 15
Mean 74 56 * 46 * 32 19 *
±SD (±11) (±8) (±7) (±10) (±4)
ANOVA p value 0.0001 0.0001
Post-hoc compared to rest * denotes p b 0.01
iRVEDV indicates indexed right ventricular end-diastolic volume; iRVESV, indexed right ventric
cardiac output.CI with no change in SV. These studies involved older patients with
mixed systemic ventricular morphology. None had looked at high-
dose dobutamine, although recently, Van De Bruaene et al. [28] showed
a similar ﬁnding of no additional rise in CI between moderate and peak
exercise. The possible causes for the observed fall in SVwith peak stress
may be [1] inadequate preload, [2] abnormal systolic or diastolic myo-
cardial properties, [3] altered afterload or uncoupling of the heart, or
[4] or combination of all of these.
4.2. Preload and PVR
In Fontan circulation, the absence of a subpulmonary ventriclemight
be expected to reduce the preload of the ventricle [29]. This could lead
to an inability to respond to the higher systemic venous return needed
during stress [30,31]. In this study, the observed resting preload values
for the systemic RV were of a similar magnitude to the healthy LV
(32 × 103 ± 4 × 103 dynes/cm2) [32]. However, during dobutamine
stress changes in preload mirrored SV with an unexpected fall at peak
stress.Wewere able to unmask a limitation in the ﬁlling of the ventricle
that was not evident at resting conditions.
The observed preload response was not caused by an abnormal PVR.
Baseline PVR was normal and remained low throughout the procedure.
Schmitt et al. used a similar method for quantifying PVR [18] in an older
group of Fontan patients. Elevated resting values fell to normal during
administration of dobutamine. The difference in PVR between this
study and ours is reﬂected in the difference in ages between the two
study groups. Completion of the Fontan results in an absence of pulsatileiSV (ml/m2) APC as % of CO
0 Dob20 Rest Dob10 Dob20 Rest
21 41 45 37 14.5
13 33 35 30 10.8
10 36 43 29 27.8
19 33 34 31 22.4
18 49 39 37 12.5
18 51 43 42 0.0
9 61 39 35 7.2
20 48 39 24 21.4
17 37 29 29 6.6
12 33 25 23 6.1
16 * 42 37 32 † 12.9
(±4) (±10) (±6) (±6) (±8.6)
0.019
† denotes p b 0.05
ular systolic volume; iSV, indexed stroke volume; APC aorto-pulmonary collateral ﬂow, CO
Fig. 2.Mean effect of dobutamine stress on contractility (top left), afterload (top right), and ventriculo-arterial coupling ratio (lower).
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levels of endothelin and a higher cumulative risk of pulmonary throm-
boembolism increasing their likelihood of raised pulmonary tone. This
may explain the increased beneﬁts seen with administration of sildena-
ﬁl in older Fontan patients [28] compared to children during exercise
[33]. Interventions to improve the trans-pulmonary gradient are cur-
rently focusing on minimising power loss within the Fontan circuit
[34] and new techniques to improve the duration of forward ﬂow
through the systemic veins may offer therapeutic beneﬁts.4.3. Systolic function
Previous studies using load-dependent markers of function have
suggested that systolic function as measured by EF is reduced in those
with single systemic RV circulations compared to those with single sys-
temic LV circulations [6]. Our data for EF fall into a similar range as that
published in the literature. Interestingly, through the construction of
pressure–volume loops,wewere able to look at load-independentmea-
sures of systolic ventricular function and found contractility increased
67% in response to dobutamine 10mcg/kg/min while power output in-
creased by 114%. The systemic RV demonstrated good load-indepen-
dent systolic function albeit at a high energetic cost. The disparity in
energetic cost is related to the raising of CI through HR rather than a
SV response. Most of the external work performed by the heart is con-
sumed in overcoming systemic afterload. Increased CI mediated by HR
causes a disproportionate increase in this work. The increase in HR
seen betweenmoderate and peak dobutamine stresswaswithout an in-
crease in CI and so further reduced energy efﬁciency.4.4. Diastolic function
Findings from echocardiographic-based studies suggest diastolic ab-
normalities exist in 67–72% of patients undergoing Fontan [6,7]. How-
ever our patient cohort had normal EDP and Tau at rest. These
ﬁndings are in accordance with studies assessing function using a cath-
eterization technique [18,24]. Abnormal diastolic myocardial properties
are difﬁcult to distinguish from abnormal preload when using load-de-
pendent echocardiographic indices [35], and thismay explain the differ-
ences in ﬁndings. We assessed if diastolic dysfunction was unmasked
during stress. Interestingly, throughout dobutamine administration,
EDP remained abnormally low. However, Tau, a measure of active
early diastolic relaxation, fell, indicating improving, rather than abnor-
mal, ventricular relaxation. ThosewithHLHSoften have a dilated ventri-
cle as a consequence of the previous volume loading effects of a shunt-
dependent circulation. To account for this, we indexed EDP to the
RVEDV to provide a measure of ﬁlling pressure per millilitre of blood ‐
therewere no signiﬁcant changes. This lends further support to restrict-
ed preload rather than diastolic dysfunction as a cause for reduced car-
diac output in this group of patients.4.5. Afterload and coupling
The pressure–volume loops (Figure 3) for the systemic RV
displayed a similar pattern to that described in the literature for
those with pressure-loaded RVs [36]. During administration of dobu-
tamine, a gradual increase in the afterload was observed. However,
the systemic RV matched the increased hydraulic load by increasing
ab
Fig. 3. (a) Pressure–volume loops for all of the studies: at rest (left);with dobutamine at 10mcg/kg/min (middle); andwith dobutamine at 20mcg/kg/min (right). Volumes are indexed to
body surface area to allow comparison of loops. (b) Response of power (left) and stroke work (right) to dobutamine.
444 J. Wong et al. / International Journal of Cardiology 230 (2017) 439–446Ees. Under resting conditions, the systemic RV has a ventriculo-
arterial coupling ratio that compares favourably to the healthy LV
[37] and this remained well matched throughout the application ofTable 4
Cardiac diastolic function.
ID EDP (mmHg) Tau
Rest Dob10 Dob20 Rest Dob10 D
1 8.0 4.8 7.0 28.9 22.8 17
2 7.5 9.5 6.0 12.5 6.4 4.
3 12.5 11.5 10.5 45.7 22.0 18
4 4.5 4.5 4.0 28.7 27.0 8.
5 12.0 9.0 10.7 28.6 12.4 4.
6 3.5 4.0 6.0 18.0 13.0 6.
7 10.7 9.5 11.0 62.5 18.8 27
8 5.0 2.0 2.0 18.4 18.8 14
9 10.0 10.0 7.0 28.8 23.4 19
10 6.5 6.3 3.8 22.6 30.7 21
Mean 8.1 7.4 7.1 30.1 19.3 13
±SD ±3.1 ±2.8 (±2.7) (14.3) (7.4) (8
ANOVA p value 0.72 0.005
Post hoc compared to rest * denotes p b 0.01
EDP indicates end-diastolic pressure, Tau is the early relaxation constant, PVR pulmonary vascpharmacological stress indicating good energetic efﬁciency [38,39].
The systemic RV displayed good contractile reserve and effective
coupling during stress may explain the limited beneﬁt found fromPreload ×103 dynes/cm2 PVR (WU.m2)
ob20 Rest Dob10 Dob20 Rest Dob10 Dob20
.7 80 33 28 0.9 1.7 1.7
3 68 61 27 0.9 0.42 2.0
.5 77 53 28 0.8 1.5 1.6
8 37 27 25 2.1 2.5 2.1
6 81 41 36 1.0 0.5 0.5
3 19 18 16 0.9 0.8 0.8
.0 89 70 46 0.95 0.9 1.1
.2 36 46 36 1.5 1.8 1.7
.8 42 31 22 1.9 1.8 1.5
.6 32 16 19 4.4 3.7 3.4
.8 * 52 36 26 † 1.7 1.7 1.8
.0) (30) (19) (10) (±1.2) (±1.1) (±0.8)
0.037 0.97
† denotes p b 0.05
ular resistance.
Fig. 4. Relationship of mean preload to mean indexed SV. Standard deviation bars are
shown. The fall in stroke volume with increasing dobutamine stress is matched by a fall
in preload.
445J. Wong et al. / International Journal of Cardiology 230 (2017) 439–446administering afterload-reducing agents to this group of patients
during exercise [40].
4.6. Aorto-pulmonary collaterals
Schmitt and colleagues [18] demonstrated the contribution of mean
APC ﬂow on cardiac output doubles during stress. We quantiﬁed APC
contribution only during resting conditions due to the length of the
study. Our baseline values were of similarmagnitude andwewould ex-
pect them to increase in the same way. APC ﬂow has the beneﬁt of con-
tributing to preload but leads to diversion of blood from systemic
perfusion. Despite this contribution, it was unable to offset a fall in pre-
load and EDP under peak stress conditions.
5. Limitations
In those with a Fontan circulation, peripheral muscle contractions
and respiratory effort play a prominent role in driving blood through
the systemic veins [41]. Care must be taken interpreting data from
anaesthetised patients performing breath-holds. However, the results
of this study correspond to those observed by subjects undergoing
CPET, namely, a limited CI and fall in SV [3]. In a recent study, assessing
the effects of supine cycling on CI in adults with single ventricle circula-
tions [28], SV fell with the highest levels of exertion corresponding to
the highest level of dobutamine administered in this study. Pharmaco-
logical stressmimicsmany of the physiological changes the heart is sub-
jected to during exertion andwas useful in our patient groupwho were
too small to ride an exercise bike.
The patients in this study were anaesthetised using sevoﬂuorane
and remifentanil. We tried to manage the patients with the lowest
doses of these drugs to maintain effective anaesthesia. The effects of
sevoﬂuorane on loading conditions and contractility have been exten-
sively studied in animals [42]. It demonstrates a dose-dependent effect
including decreases in systolic arterial pressure, heart rate, cardiac
index, left ventricular minute work index, maximum rate of rise of left
ventricular pressure (LV dP/dt), and systemic vascular resistance.
There were no effects on stroke volume and left ventricular end-
diastolic pressure. High-dose remifentanil has been shown to reduce
indexed stroke volume, heart rate, and mean arterial blood pressure[43]. However, the synergistic effects of these two anaesthetic agents
appear to alter the loading conditions and contractility on the heart in
different ways to their individual actions. A study performed in 2005
by Chanavaz [44] used echocardiography in a group of children under-
going anaesthesia to assess ventricular function at baseline with
sevoﬂuorane and then reassess the following addition of remifentanil.
The addition of remifentanil was found to reduce heart rate, blood pres-
sure, and cardiac index. However, it led to increased systemic vascular
resistancewith a fall in contractility which is not in keepingwith the ac-
tions of either drug alone. The effects of these anaesthetic drugs are dose
dependent. As we maintained effective anaesthesia with the lowest
dose as possible these haemodynamic effects would have been
minimised. Indeed, in an earlier study carried out by our group [4], we
compared cardiac function in subjects with HLHS-Fontan to a control
group of awake healthy adult subjects. There were no signiﬁcant differ-
ences in indexed end-diastolic volume, indexed end-systolic function
and indexed stroke volume. This indicates that through the use of
low-dose anaesthetic agents and careful management of physiological
parameters we may have been able to alleviate some of the published
haemodynamic effects of higher dose general anaesthesia during our
study protocol.
The systemic RV is not a true prolate ellipsoid. Although other for-
mulas for preload exist speciﬁc to the RV, in HLHS, the septal wall is
thought of belonging to the systemic RV so a modiﬁed formula for idio-
pathic hypertension is not applicable [45]. Stress represents a mean
value across the entire RV wall, with the potential to underestimate
stress on the endocardial layer and in regional areas where themyocar-
diummay be thicker (commonly the septal wall in thosewith a residual
LV). As a comparative estimation, it broadly serves its purpose.
The single-beat estimation method was originally conceived for the
LV and has been validated in the RV. Early work on the systemic RV has
been performed [18,46] and our results are in keeping with these ﬁnd-
ings. Altering preload would have offered a load-independent measure
of diastolic function, the end-diastolic-pressure–volume relationship.
However, acquiring MRI volumetric data within a suitable timeframe
is not yet feasible. Tau was used instead although it primarily assesses
early diastolic relaxation.6. Conclusions
Children with HLHS-Fontan display a blunted response in CI and a
fall in SV at peak stress due to a failure to adequately preload the
heart. The HR-driven response makes this an energetically costly pro-
cess. PVR remains low, systolic and diastolic functional indices tend to
be normal, and the ventricle is well coupled to the hydraulic load. In
young patients introducing measures that focus on improving the pre-
load of the heart may offer the most beneﬁts.Funding
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